Chimerix to Participate in Upcoming Investor Conferences
05 September 2023 - 1:00PM
Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose
mission is to develop medicines that meaningfully improve and
extend the lives of patients facing deadly diseases, today
announced that management will participate in two upcoming investor
conferences:
- H.C. Wainwright 25th Annual Global Investment
Conference in New York City. Mike Andriole, Chief
Executive Officer, will present a corporate overview on September
12, 2023 at 9:00 a.m. ET. A live audio webcast of the presentation
can be accessed here and on the Investor Relations section of
Chimerix’s website at ir.chimerix.com where it will be archived for
approximately 90 days.
- Baird 2023 Global Healthcare Conference on
September 13, 2023 in New York City, where management will
participate in 1x1 meetings.
About Chimerix
Chimerix is a biopharmaceutical company with a mission to
develop medicines that meaningfully improve and extend the lives of
patients facing deadly diseases. The Company’s most advanced
clinical-stage development program, ONC201, is in development for
H3 K27M-mutant glioma.
CONTACTS:
Michelle LaSpaluto919 972-7115ir@chimerix.com
Will O’ConnorStern Investor
Relations212-362-1200will@sternir.com
Chimerix (NASDAQ:CMRX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Chimerix (NASDAQ:CMRX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024